Filing Flows › Bausch & Lomb (BLCO) › Q1 2026
Bausch & Lomb (BLCO) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 29, 2026
Bausch & Lomb (BLCO) reported revenue of $1.2B for the first quarter 2026 (Q1 2026), +9% from a year earlier and -11% from the quarter before. Operating margin was 2.7%, net loss $70.0M (5.6% of revenue).
Bausch & Lomb, Q1 2026: revenue $1.2B (+9% year over year), operating margin 2.7%, net loss $70.0M, operating cash flow $32.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2B | -11% | +9% |
| Operating profit | $33.0M | -71% | — |
| Net earnings | −$70.0M | — | — |
| Operating cash flow | $32.0M | -76% | — |
What changed
Revenue was $1.2B in Q1 2026, up 9% year over year and down 11% from the previous quarter. Devices was the largest line at 39% of revenue. Pharmaceuticals added $0.04B year over year (up 20%), 41% of the total change. Branded and Other Generics declined 9%.
Operating profit was $0.03B, a 2.7% margin (up 10.0 points year over year). Total costs fell 1% while revenue rose 9%. The fastest-growing cost line was Research & development (+17%). The quarter ended with a net loss of $0.07B, wider than the previous quarter's $0.06B loss. Net interest and other expense of $0.10B was the main reason.
Operating cash flow was $0.03B. Non-cash charges added back $0.10B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items used $0.03B. Capital expenditures of $0.10B exceeded it, leaving free cash flow of −$0.07B.
Questions
What was Bausch & Lomb's revenue in the first quarter 2026?
Bausch & Lomb (BLCO) reported revenue of $1.2B for the first quarter 2026 (Q1 2026), +9% from a year earlier and -11% from the quarter before.
Was Bausch & Lomb profitable in the first quarter 2026?
Operating profit was $33.0M (2.7% of revenue) and net loss $70.0M.
Source: Bausch & Lomb 10-Q on SEC EDGAR.